DK1067913T3 - Sammensætninger og fremgangsmåder til justering af steroidhormonmetabolisme ved faciliteret absorbering af hydrofobe, diætetiske forbindelser - Google Patents
Sammensætninger og fremgangsmåder til justering af steroidhormonmetabolisme ved faciliteret absorbering af hydrofobe, diætetiske forbindelserInfo
- Publication number
- DK1067913T3 DK1067913T3 DK99915193.9T DK99915193T DK1067913T3 DK 1067913 T3 DK1067913 T3 DK 1067913T3 DK 99915193 T DK99915193 T DK 99915193T DK 1067913 T3 DK1067913 T3 DK 1067913T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- methods
- steroid hormone
- hormone metabolism
- dietary compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/053,180 US6086915A (en) | 1998-04-01 | 1998-04-01 | Compositions and methods of adjusting steroid hormone metabolism through phytochemicals |
PCT/US1999/007178 WO1999049851A1 (en) | 1998-04-01 | 1999-04-01 | Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1067913T3 true DK1067913T3 (da) | 2012-12-17 |
Family
ID=21982444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99915193.9T DK1067913T3 (da) | 1998-04-01 | 1999-04-01 | Sammensætninger og fremgangsmåder til justering af steroidhormonmetabolisme ved faciliteret absorbering af hydrofobe, diætetiske forbindelser |
Country Status (9)
Country | Link |
---|---|
US (1) | US6086915A (da) |
EP (1) | EP1067913B1 (da) |
AU (1) | AU763358B2 (da) |
CA (1) | CA2326653C (da) |
CZ (1) | CZ300840B6 (da) |
DK (1) | DK1067913T3 (da) |
NZ (1) | NZ507637A (da) |
PT (1) | PT1067913E (da) |
WO (1) | WO1999049851A1 (da) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19913606A1 (de) * | 1999-03-25 | 2000-09-28 | Basf Ag | Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen |
US6534085B1 (en) * | 1999-09-23 | 2003-03-18 | Bioresponse L.L.C. | Phytochemicals for promoting weight loss |
US6689387B1 (en) * | 1999-09-23 | 2004-02-10 | Bioresponse Llc | Phytochemicals for treatment of mastalgia and endometriosis |
US7384971B2 (en) * | 1999-09-23 | 2008-06-10 | Bioresponse L.L.C. | Phytochemicals for the treatment of cervical dysplasia |
DE10000792A1 (de) * | 2000-01-11 | 2001-07-19 | Bernhard C Lippold | Formulierungen von Wirkstoffen in Form einer festen Dispersion |
EP1136073A1 (en) * | 2000-03-22 | 2001-09-26 | N.V. Nutricia | Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
US6416793B1 (en) | 2000-07-11 | 2002-07-09 | Bioresponse, L.L.C. | Formulations and use of controlled-release indole alkaloids |
US6326366B1 (en) * | 2000-08-22 | 2001-12-04 | Protein Technologies International | Hormone replacement therapy |
DE10054294A1 (de) * | 2000-11-02 | 2002-05-16 | Heinrich Wieland | Topische Behandlung bei der Mastalgie |
US6605605B2 (en) * | 2000-11-13 | 2003-08-12 | Milton Hammerly | Estrogenic substances combined with cruciferous indole compounds |
CA2445963A1 (en) * | 2001-05-02 | 2002-11-07 | Kgk Synergize Inc. | Polymethoxylated flavones for treating insulin resistance |
US6607755B2 (en) * | 2001-06-21 | 2003-08-19 | Michael Donald Farley | Anti-aromatase pharmaceutical composition for controlling testosterone/estrone ratios |
US7348352B2 (en) * | 2001-10-23 | 2008-03-25 | Bioresponse L.L.C. | Diindolylmethane for the treatment of HPV infection |
US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
BR0313182A (pt) | 2002-07-24 | 2007-07-24 | Childrens Hosp Medical Center | composições e produtos contendo equol enantiomérico |
AU2003286781B2 (en) | 2002-10-29 | 2009-05-21 | Brigham Young University | Use of equol for treating androgen mediated diseases |
US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
DE60321227D1 (de) * | 2003-01-09 | 2008-07-03 | Michael D Farley | Zytotoxische pharmazeutische zusammensetzung |
US20040253319A1 (en) * | 2003-06-11 | 2004-12-16 | Shrirang Netke | Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy |
BRPI0415858A (pt) * | 2003-10-29 | 2007-01-09 | Sonus Pharma Inc | compostos de medicamentos terapêuticos modificados por tocoferol |
US7410654B2 (en) * | 2004-01-30 | 2008-08-12 | Katsumi Koide | Pollen manufacturing method |
WO2005107747A2 (en) * | 2004-05-06 | 2005-11-17 | Bioresponse, Llc | Diindolymethane formulations for the treatment of leiomyomas |
US20150005360A1 (en) | 2004-10-25 | 2015-01-01 | Nse Products, Inc. | Phytoestrogen compositions and associated methods |
US7989486B2 (en) * | 2004-12-30 | 2011-08-02 | Bioresponse, L.L.C. | Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions |
US20060153926A1 (en) * | 2005-01-10 | 2006-07-13 | Bascom Charles C | Compositions, products and methods for controlling weight in a mammal |
EP1865929A2 (en) * | 2005-03-28 | 2007-12-19 | Bioresponse, L.L.C. | Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
JP2009503071A (ja) * | 2005-08-03 | 2009-01-29 | イーストマン ケミカル カンパニー | トコフェリルポリエチレングリコールスクシネート粉末及びその製造方法 |
US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US7998500B2 (en) | 2005-08-04 | 2011-08-16 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US7901710B2 (en) | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
EP2063861B1 (en) * | 2006-09-15 | 2015-02-25 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
US8586621B2 (en) | 2006-10-27 | 2013-11-19 | Michael A. Zeligs | Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles |
WO2008086400A2 (en) * | 2007-01-09 | 2008-07-17 | Isp Investments Inc. | Sirtuin-activating compounds of enhanced bioavailability |
PA8768201A1 (es) * | 2007-02-05 | 2009-01-23 | Wyeth Corp | Composiciones farmacéuticas que contienen derivados de ácido indol sustituidos como inhibidores del inhibidor del activador de plasminógeno 1 (pai-1) |
WO2009103754A2 (en) * | 2008-02-19 | 2009-08-27 | Dsm Ip Assets B.V. | Novel use of 3,3'-diindolylmethane |
EP2548456B1 (en) | 2008-03-20 | 2015-07-08 | Virun, Inc. | Emulsions including a PEG-derivative of tocopherol |
CN102036661B (zh) * | 2008-03-20 | 2016-12-28 | 维尔恩公司 | 维生素衍生物及其用途 |
RU2409363C9 (ru) * | 2009-09-18 | 2013-12-10 | Всеволод Иванович Киселев | Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций |
CN102058528B (zh) * | 2009-11-13 | 2012-12-12 | 中国科学院上海药物研究所 | 一种黄豆苷元胶束及其制备方法 |
US9320295B2 (en) * | 2010-03-23 | 2016-04-26 | Virun, Inc. | Compositions containing non-polar compounds |
US9655849B2 (en) | 2011-03-18 | 2017-05-23 | Particle Dynamics International, Llc | Solid particulate compositions comprising coenzyme Q10 |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
MX2015013160A (es) * | 2013-03-15 | 2016-04-04 | Cba Pharma Inc | Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos. |
JP2016514142A (ja) | 2013-03-15 | 2016-05-19 | シービーエー・ファーマ・インコーポレイテッドCba Pharma, Inc. | 薬物及び栄養補助剤のバイオアベイラビリティを高める方法及び生成物 |
US9132117B2 (en) | 2013-06-17 | 2015-09-15 | Kgk Synergize, Inc | Compositions and methods for glycemic control of subjects with impaired fasting glucose |
US9693574B2 (en) | 2013-08-08 | 2017-07-04 | Virun, Inc. | Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch |
WO2015042170A1 (en) | 2013-09-17 | 2015-03-26 | Wayne State University | Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds |
WO2016164770A1 (en) * | 2015-04-10 | 2016-10-13 | Bioresponse, L.L.C. | Self-emulsifying formulations of dim-related indoles |
CN109045302B (zh) * | 2018-08-22 | 2021-08-06 | 武汉桀升生物科技有限公司 | 一种聚乙二醇维生素e琥珀酸酯粉末及其制备方法和应用 |
AU2021240819A1 (en) * | 2020-03-26 | 2022-11-24 | smartDNA Pty Ltd | Quercetin enhancement formulation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3185625A (en) * | 1961-11-08 | 1965-05-25 | Brown Ethan Allan | Injectionable substances |
US4151273A (en) * | 1974-10-31 | 1979-04-24 | The Regents Of The University Of California | Increasing the absorption rate of insoluble drugs |
US4230687A (en) * | 1978-05-30 | 1980-10-28 | Griffith Laboratories U.S.A., Inc. | Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices |
DE3049380A1 (de) * | 1980-12-29 | 1982-07-08 | Rudolf 8034 Germering Schanze | Verfahren zur herstellung eines ein bienenprodukt enthaltenden konzentrats, bienenprodukt enthaltendes konzentrat und seine verwendung |
FR2525108B1 (fr) * | 1982-04-19 | 1989-05-12 | Elan Corp Ltd | Medicaments a haut degre de solubilite et procede pour leur obtention |
ES2071332T3 (es) * | 1990-08-13 | 1995-06-16 | David W Yesair | Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias. |
JPH06107555A (ja) * | 1992-04-17 | 1994-04-19 | Chong-Kook Kim | 牛黄清心マイクロカプセル及びその製造方法 |
US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
-
1998
- 1998-04-01 US US09/053,180 patent/US6086915A/en not_active Expired - Lifetime
-
1999
- 1999-04-01 WO PCT/US1999/007178 patent/WO1999049851A1/en active IP Right Grant
- 1999-04-01 AU AU33772/99A patent/AU763358B2/en not_active Expired
- 1999-04-01 PT PT99915193T patent/PT1067913E/pt unknown
- 1999-04-01 NZ NZ507637A patent/NZ507637A/en not_active IP Right Cessation
- 1999-04-01 CA CA2326653A patent/CA2326653C/en not_active Expired - Lifetime
- 1999-04-01 CZ CZ20003583A patent/CZ300840B6/cs not_active IP Right Cessation
- 1999-04-01 EP EP99915193A patent/EP1067913B1/en not_active Expired - Lifetime
- 1999-04-01 DK DK99915193.9T patent/DK1067913T3/da active
Also Published As
Publication number | Publication date |
---|---|
AU763358B2 (en) | 2003-07-17 |
EP1067913A4 (en) | 2009-03-11 |
US6086915A (en) | 2000-07-11 |
AU3377299A (en) | 1999-10-18 |
NZ507637A (en) | 2003-11-28 |
CA2326653A1 (en) | 1999-10-07 |
PT1067913E (pt) | 2012-12-17 |
EP1067913B1 (en) | 2012-08-29 |
EP1067913A1 (en) | 2001-01-17 |
CZ20003583A3 (cs) | 2001-11-14 |
CZ300840B6 (cs) | 2009-08-26 |
CA2326653C (en) | 2010-11-30 |
WO1999049851A1 (en) | 1999-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1067913T3 (da) | Sammensætninger og fremgangsmåder til justering af steroidhormonmetabolisme ved faciliteret absorbering af hydrofobe, diætetiske forbindelser | |
DK0785792T3 (da) | Præparat til behandling af ovariale af østrogen afhængige sygdomme | |
DK0979034T3 (da) | Præparat til bekæmpelse af skadelige bioorganismer og fremgangsmåde til bekæmpelse af skadelige bioorganismer ved anvendelse af dette | |
AU2001297830A1 (en) | Closed substrate platforms suitable for analysis of biomolecules | |
AU1920800A (en) | Methods for designing standard cell transistor structures | |
DK1008577T3 (da) | Fremgangsmåde til fremstilling af methanol | |
AU7986700A (en) | Method of treating inflammatory conditions with progesterone or progesterone analogs | |
AU7962498A (en) | In-line cell for absorption spectroscopy | |
AU2001259479A1 (en) | Method for broadcasting using satellites and the internet | |
AU3046299A (en) | Method and compositions for water control | |
AU3360399A (en) | Composition and method for removing photoresist materials from electronic components | |
IS5740A (is) | Samsetning sem samanstendur af karnitíni, glútaþíóni (glutathione) gagnlegu til að auka gleypni glútaþíóns og samverka áhrif þess | |
DK1140824T3 (da) | Fremgangsmåde til fremstilling af 3-alkanoyl- og 3-alkylindoler | |
AU2001247620A1 (en) | Method for analysis of analytes by mass spectrometry | |
AU2993599A (en) | Regulation of the cell cycle by sterols | |
AU5038800A (en) | Copper source reagent compositions, and method of making and using same for microelectronic device structures | |
AU2002358484A1 (en) | Solid binding agents hardened by means of radiation | |
DK0776904T3 (da) | Fremgangsmåde til fremstilling af steroidderivatketal | |
AU4926499A (en) | In-line cell for absorption spectroscopy | |
AU4330997A (en) | Method for analysing absorption, distribution, metabolism, excretion (ADME) an d pharmacokinetics properties of compound mixtures | |
AU2001274066A1 (en) | Method and device for the accelerated setting and hardening of hydraulically effective cements and binding agents and compositions thereof | |
AU3567299A (en) | Phytosterol formulations to lower cholesterol absorption | |
GB9812048D0 (en) | Means for combining extendible,coilable members to create compound struts | |
DK0923599T3 (da) | Fremgangsmåde til fremstilling af 17-estere af 9alfa, 21-dihalogenpregnan-11beta, 17alfa-diol-20-oner | |
AU2002340879A1 (en) | Method for the translation of programs for reconfigurable architectures |